SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-20-008321
Filing Date
2020-08-03
Accepted
2020-08-03 16:10:01
Documents
3
Period of Report
2020-08-13
Effectiveness Date
2020-08-03

Document Format Files

Seq Description Document Type Size
1 CONSENT SOLICITATION ndra_def14a.htm DEF 14A 184239
2 IMAGE ndra_pre14a000.jpg GRAPHIC 6705
3 IMAGE ndra_pre14a001.jpg GRAPHIC 6700
  Complete submission text file 0001654954-20-008321.txt   204148
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37969 | Film No.: 201069312
SIC: 3845 Electromedical & Electrotherapeutic Apparatus